시장보고서

상품코드

1808900

세계의 지혈 진단 시장 : 검사별, 제품 유형별, 최종 사용자별, 국가별, 지역별 산업 분석, 시장 규모, 점유율, 예측(2024-2032년)

Hemostasis Diagnostics Market, By Test, By Product Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2025년 08월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 260 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

2024년 지혈 진단 시장의 규모는 11억 9,023만 달러였으며 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 4.59%로 확대될 전망입니다.

지혈 진단에는 출혈을 멈추는 신체의 능력, 즉 혈액 응고 시스템이 얼마나 잘 작동하는지에 대한 의학적 검사와 평가가 포함됩니다. 이러한 진단은 출혈성 질환이나 혈전증과 같은 응고 장애를 확인하고 혈액 희석 요법과 같은 항응고제를 복용하는 환자를 모니터링하는 데 매우 중요합니다.

지혈 진단 시장 역학

만성 혈액 질환의 유병률 증가와 지혈 검사에 대한 높은 수요가 시장 수요를 촉진할 전망

지혈 진단 시장은 혈우병, 폰빌레브란트병, 혈소판 감소증, 심부정맥 혈전증(DVT) 등 출혈성 질환과 혈액 응고 장애의 이환율 증가가 시장을 견인하고 있습니다. 세계 혈우병 연맹에 따르면 세계적으로 40만 명 이상이 혈우병을 앓고 있으며, 대부분 정기적인 모니터링과 검사가 필요하기 때문에 시장 성장에 박차를 가하고 있습니다. 또한 심혈관 질환, 간 질환, 암 질환에서는 혈전증이나 출혈 등의 합병증을 예방 및 관리하기 위해 정기적인 응고 검사가 필요합니다. 예를 들어, 화학요법을 받고 있는 암 환자는 응고 프로파일이 변화할 수 있으며, 정기적인 진단 검사가 필요합니다. 고령자는 혈액 응고장애를 일으키기 쉽고, 심방세동, 뇌졸중 예방, 수술 후 등의 이유로 항응고요법을 필요로 하는 사람이 많습니다. 수술 중에서도 특히 정형외과 및 심장혈관 수술의 증가로 수술 전 응고 스크리닝의 사용이 증가하고 있으며, 지혈 진단에 대한 수요가 더욱 높아지고 있습니다.

또한 출혈과 응고 장애의 조기 발견과 관리의 중요성에 대한 인식이 세계적으로 증가하고 있습니다. 정부 프로그램, 건강 단체에 의한 옹호 활동, 의료 캠페인에 의해 이러한 질환에 대한 일반 시민이나 임상의의 이해가 향상하고 있습니다. 그 결과, 특히 선진국이나 중소득국에서는 스크리닝이나 진단률이 증가하고 있습니다. 또한 TEG(트롬보엘라스토그래피)와 ROTEM(회전식 트롬보엘라스토메트리) 등 점탄성 검사 기술의 도입은 치명상 관리, 수술, 외상 현장에서 응고 모니터링에 혁명을 일으켰습니다. 이러한 검사는 혈전의 형성과 용해를 동적이고 실시간으로 보여주며, 보다 신속한 임상 판단을 가능하게 합니다.

지혈 진단 시장 - 주요 고려 사항

당사의 리서치 애널리스트의 분석에 따르면 세계 시장은 예측 기간(2024-2032년)에 약 4.59%의 연평균 복합 성장률(CAGR)로 연간 성장할 것으로 예측됩니다.

검사별로는 프로트롬빈 시간 검사 부문이 사용 편의성과 최소한의 교육으로 인한 높은 비용효율성으로 2024년 최대 시장 점유율을 보였습니다.

제품 유형별로는 소모품 부문이 2024년 주요 제품 유형으로 나타났습니다. 이는 세계 의료에 대한 접근성이 증가함에 따라 소모품에 대한 수요가 증가하고 있기 때문입니다.

최종 사용자별로는 병원에서 응고 장애의 진단과 관리가 필요하기 때문에 병원이 2024년 주요 최종 사용자로 나타났습니다.

지역별로는 정맥혈전증과 심방세동의 유병률이 높기 때문에 북미가 2024년 매출을 주도하였습니다.

지혈 진단 시장 : 세분화 분석

세계의 지혈 진단 시장은 검사, 제품 유형, 최종 사용자 및 지역에 따라 구분됩니다.

시장은 검사별로 프로트롬빈 시간 검사, 피브리노겐 검사, D 다이머 검사, 활성화 부분 트롬보플라스틴 시간 검사 등의 5가지 범주로 분류됩니다. 프로트롬빈 시간 검사는 시장을 독점하고 있습니다. 출혈성 질환과 간질환의 유병률 증가가 이 분야의 수요를 끌어올리고 있습니다.

시장은 제품 유형별로 소모품, 실험실용 분석 장치, POC 검사 시스템의 3가지로 분류됩니다. 소모품 부문은 시장을 독점하고 있습니다. 소모품은 응고 검사 및 표준 진단 결과 유지에 중요한 역할을 합니다.

시장은 최종 사용자에 의해 병원, 진단 실험실 및 기타 유형의 세 가지로 분류됩니다. 병원 분야는 시장을 독점하고 있으며 예측 기간 동안 높은 우위를 유지할 것으로 예측됩니다. 병원의 치명상 치료와 응급 현장에서의 수요 증가가 시장 성장을 뒷받침하고 있습니다.

지혈 진단 시장 - 지역별 분석

세계의 지혈 진단 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 퍼져 있습니다. 미국은 높은 의료 지출, 고급 진단 인프라 및 주요 기업의 강력한 존재로 인해 단독으로 상당한 부분을 차지합니다. 유럽은 정맥 혈전 색전증(VTE)과 노화에 따른 출혈성 질환의 발생률이 높기 때문에 큰 판매 점유율을 차지하고 있습니다. 유럽에서는 병원과 진단 실험실 네트워크가 확립되었습니다. 아시아태평양은 지혈 진단 시장에서 가장 빠르게 성장하는 지역입니다. 급속한 도시화, 고령화, 의료 서비스에의 액세스 확대가 성장의 원동력이 되고 있습니다.

지혈 진단 시장 : 경쟁 구도

지혈 진단 시장은 경쟁이 치열하고 기술 주도형이며 세계적인 주요 진단제 제조업체, 지역 기업, 전문 의료기기 제조업체의 증가를 특징으로 합니다. 각 회사는 또한 세계적인 존재와 시장 점유율을 강화하기 위해 전략적 제휴, 합병 및 신제품 개발에 주력하고 있습니다. 각 회사는 특히 응급 외래 및 외과 수술 현장에서 환자 근처에서 검사할 수 있는 휴대용 지혈 진단 장치의 개발을 추진하고 있습니다. 예를 들어, Beckman Coulter와 Roche는 여러 진단 데이터 관리를 위한 통합 디지털 플랫폼에 투자하고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 튀르키예
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석 : 지혈 진단 업계

경쟁 대시보드
기업 프로파일
- Siemens Healthineers
- Roche Diagnostics
- Sysmex Corporation
- Werfen Group
- Abbott Laboratories
- Thermo Fisher Scientific
- Beckman Coulter
- Diagnostica Stago
- HemoSonics(Stago Group)
- Horiba Medical
- Trinity Biotech
- Helena Laboratories
- BioMerieux
- BD
- Grifols SA
- Medtronic
- Others

12장 애널리스트의 종합적 전망

CSM 25.09.25

Hemostasis Diagnostics Market size was valued at USD 1,190.23 Million in 2024, expanding at a CAGR of 4.59% from 2025 to 2032.

Hemostasis diagnostics involves medical testing and evaluation of the body's ability to stop bleeding, or in other words, how well the blood clotting (coagulation) system is functioning. These diagnostics are crucial in identifying bleeding disorders, clotting disorders like thrombosis, and monitoring patients on anticoagulants such as blood-thinning therapies.

Hemostasis Diagnostics Market- Market Dynamics

Growing prevalence of chronic & blood disorders and high demand from hemostasis testing are expected to propel market demand

Hemostasis diagnostics market is driven by the growing incidence of bleeding and clotting disorders such as hemophilia, von Willebrand disease, thrombocytopenia, and deep vein thrombosis (DVT). According to the World Federation of Hemophilia, over 400,000 people are living with hemophilia globally, many of whom require regular monitoring and testing, fueling market growth. In addition, cardiovascular diseases, liver, cancer conditions require regular coagulation testing to prevent or manage complications like thrombosis or hemorrhage. For example, cancer patients undergoing chemotherapy may have altered coagulation profiles, necessitating regular diagnostic testing. Older adults are more prone to blood coagulation issues, and many require anticoagulant therapy for conditions such as atrial fibrillation, stroke prevention, and after surgical procedures. The increase in surgeries, particularly orthopedic and cardiovascular surgeries, has led to greater use of pre-operative coagulation screening, further fueling demand for hemostasis diagnostics.

Further, there is a growing global awareness of the importance of early detection and management of bleeding and clotting disorders. Government programs, advocacy by health organizations, and medical campaigns have improved public and clinical understanding of these conditions. As a result, screening and diagnostic rates have improved, especially in developed and middle-income countries. Moreover, the introduction of viscoelastic testing technologies such as TEG (Thromboelastography) and ROTEM (Rotational Thromboelastometry) has revolutionized coagulation monitoring in critical care, surgery, and trauma settings. These tests provide a dynamic and real-time view of clot formation and dissolution, enabling faster clinical decision-making.

Hemostasis Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.59% over the forecast period (2024-2032)

Based on Test segmentation, prothrombin time test segment was predicted to show maximum market share in the year 2024, owing to its ease of use and high-cost effectiveness with minimal training.

Based on Product Type segmentation, consumables segment was the leading Product Type in 2024, due to high demand for consumables as healthcare access increases across the globe.

Based on End User segmentation, hospitals segment was the leading End User in 2024, owing to need for diagnosis & managing coagulation disorders at hospitals.

On the basis of the region, North America was the leading revenue generator in 2024, owing to high prevalence of vein thrombosis & atrial fibrillation.

Hemostasis Diagnostics Market- Segmentation Analysis:

The Global Hemostasis Diagnostics Market is segmented on the basis of Test, Product Type, End User, and Region.

The market is divided into five categories based on Test: prothrombin time test, fibrinogen test, D-dimer test, activated partial thromboplastin time test, and others. The prothrombin time test segment dominates the market. Increasing prevalence of bleeding disorders, liver diseases is boosting segment demand.

The market is divided into three categories based on Product Type: consumables, laboratory analyzers, and PoC testing systems. The consumables segment dominates the market. Consumables play vital role in coagulation testing and maintaining standard diagnostic results.

The market is divided into three categories based on the End User: hospitals, diagnostic laboratories, and others. The hospitals segment dominates the market and is expected to maintain its high dominance during the forecast period. Growing demand from critical care & emergency settings in hospitals is fueling market growth.

Hemostasis Diagnostics Market- Geographical Insights

Worldwide, the Hemostasis Diagnostics market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa North America holds the largest market share globally in hemostasis diagnostics. The U.S. alone accounts for a significant portion due to its high healthcare spending, advanced diagnostic infrastructure, and strong presence of key players. Europe holds significant revenue share due to high incidence of venous thromboembolism (VTE) and age-related bleeding disorders. Well-established hospital and diagnostic laboratory networks. Asia Pacific is the fastest-growing region in the hemostasis diagnostics market. Rapid urbanization, aging population, and expanding access to healthcare services are driving growth.

Hemostasis Diagnostics Market- Competitive Landscape:

The hemostasis diagnostics market is highly competitive and technology-driven, characterized by the presence of global diagnostic giants, regional players, and a growing number of specialized medical device companies. Companies are also focusing on strategic partnerships, mergers, and new product development to strengthen their global presence and market share. Companies are developing portable hemostasis diagnostic devices for near-patient testing, especially in emergency rooms and surgical settings. For example, Beckman Coulter and Roche are investing in integrated digital platforms for multi-diagnostic data management.

Recent Developments:

In April 2024, Haemonetics Corporation received an U.S. FDA clearance for its Global Hemostasis-HN assay cartridge.

In September 2024, Sysmex Corporation introduced HISCL HIT IgG Assay Kit, that enables the detection of IgG antibodies for patients undergoing heparin therapy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMOSTASIS DIAGNOSTICS MARKET KEY PLAYERS

Siemens Healthineers
Roche Diagnostics
Sysmex Corporation
Werfen Group
Abbott Laboratories
Thermo Fisher Scientific
Beckman Coulter
Diagnostica Stago
HemoSonics (Stago Group)
Horiba Medical
Trinity Biotech
Helena Laboratories
BioMerieux
BD
Grifols S.A.
Medtronic
Others

GLOBAL HEMOSTASIS DIAGNOSTICS MARKET, BY TEST- MARKET ANALYSIS, 2019-2032

Prothrombin time test
Fibrinogen test
D-dimer test
Activated partial thromboplastin time test
Others

GLOBAL HEMOSTASIS DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

Consumables
Laboratory analyzers
PoC testing systems

GLOBAL HEMOSTASIS DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

Hospitals
Diagnostic laboratories
Others

GLOBAL HEMOSTASIS DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Hemostasis Diagnostics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Hemostasis Diagnostics Market Snippet by Test
- 2.1.2. Hemostasis Diagnostics Market Snippet by Product Type
- 2.1.3. Hemostasis Diagnostics Market Snippet by End User
- 2.1.4. Hemostasis Diagnostics Market Snippet by Country
- 2.1.5. Hemostasis Diagnostics Market Snippet by Region
2.2. Competitive Insights

3. Hemostasis Diagnostics Key Market Trends

3.1. Hemostasis Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Hemostasis Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Hemostasis Diagnostics Market Opportunities
3.4. Hemostasis Diagnostics Market Future Trends

4. Hemostasis Diagnostics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Hemostasis Diagnostics Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Hemostasis Diagnostics Market Landscape

6.1. Hemostasis Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Hemostasis Diagnostics Market - By Test

7.1. Overview
- 7.1.1. Segment Share Analysis, By Test, 2024 & 2032 (%)
- 7.1.2. Prothrombin time test
- 7.1.3. Fibrinogen test
- 7.1.4. D-dimer test
- 7.1.5. Activated partial thromboplastin time test
- 7.1.6. Others

8. Hemostasis Diagnostics Market - By Product Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 8.1.2. Consumables
- 8.1.3. Laboratory analyzers
- 8.1.4. PoC testing systems

9. Hemostasis Diagnostics Market - By End User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 9.1.2. Hospitals
- 9.1.3. Diagnostic laboratories
- 9.1.4. Others

10. Hemostasis Diagnostics Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Hemostasis Diagnostics Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Hemostasis Diagnostics Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Hemostasis Diagnostics Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Hemostasis Diagnostics Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Hemostasis Diagnostics Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Hemostasis Diagnostics Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Siemens Healthineers
- 11.2.2. Roche Diagnostics
- 11.2.3. Sysmex Corporation
- 11.2.4. Werfen Group
- 11.2.5. Abbott Laboratories
- 11.2.6. Thermo Fisher Scientific
- 11.2.7. Beckman Coulter
- 11.2.8. Diagnostica Stago
- 11.2.9. HemoSonics (Stago Group)
- 11.2.10. Horiba Medical
- 11.2.11. Trinity Biotech
- 11.2.12. Helena Laboratories
- 11.2.13. BioMerieux
- 11.2.14. BD
- 11.2.15. Grifols S.A.
- 11.2.16. Medtronic
- 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us